Chinese researchers have unveiled a breakthrough experimental therapy that could one day protect humans from the deadly ...

The recent authorization by the FDA of the inaugural gene therapy for genetic-related hearing impairment signifies a ...

Phase 2 trial results showed an improvement in MASH with no worsening of fibrosis in all treatment groups compared with placebo. The Food and Drug Administration (FDA) has granted Breakthrough Therapy ...

Merck & Co., Inc. (NYSE:MRK) is one of the top 10 undervalued blue chip stocks analysts recommend for smart investing. Merck ...

Nipocalimab 15mg/kg improved ClinESSDAI score compared with placebo (treatment difference -2.65; [90% CI, -4.03, -1.28]; P =.002). The Food and Drug Administration (FDA) has granted Breakthrough ...

A single jab of a breakthrough gene therapy could reverse hearing loss in people within weeks, according to new research. The cutting-edge therapy improved hearing in children and adults with ...

Please provide your email address to receive an email when new articles are posted on . The FDA has granted breakthrough therapy designation to nipocalimab, a novel neonatal Fc receptor blocker, for ...

Atrioventricular Interval Modulation (“AVIM”) Therapy Food and Drug Administration (“FDA”) Breakthrough Device Designations span the broader population of patients with uncontrolled hypertension ...

A new study by ieso Digital Health in collaboration with the NHS and NIHR BioResource reveals that its AI-driven digital programme delivered results comparable to traditional human-led therapy for ...